To corroborate the regulation of antimicrobial activity in macrophages by SLC7A11, BMDMs were treated with erastin, a pharmacological inhibitor of SLC7A11, or with siRNA-mediated Slc7a11 silencing (si-Slc7a11) before infection with S. aureus. The gene discussed is SLC7A11; the disease is infection.